More Orthocell Ltd news
Orthocell LtdASX: OCC

CelGro Study Results Open Up New US Market Access Strategy

Apr 27, 2021 at 11:27 PM EDT · Issued by Orthocell Ltd

Filed with ASX · Apr 27, 2021 at 11:27 PM EDT

On 6ix: 6ix.com/news/celgro-study-results-open-up-new-us-market-access-strategy

Orthocell Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Orthocell Ltd on 6ix

Earlier from Orthocell

  • CelGro gains Australian reimbursementMar 2, 2021
  • Orthocell receives new US patent for CelGroFeb 15, 2021
  • CelGro Recommended for ReimbursementFeb 4, 2021
  • Orthocell Receives A$2.3m R&D Tax Incentive RefundJan 19, 2021
  • Orthocell Receives US Market ClearanceJan 15, 2021

Later from Orthocell

  • New Collagen Rope Patent for CelGro Platform TechnologyMay 25, 2021
  • OCC Secures Patents for Sutureless Repair of Soft TissueJun 15, 2021
  • Positive CelGro Nerve Regeneration ResultsJun 20, 2021
  • Orthocell Appoints Exclusive Distributor in AustraliaJul 13, 2021
  • CelGro Facilitates Lymphatic Vessel RegenerationAug 1, 2021
All Orthocell news releases↗

Follow Orthocell into a list and get an email when it puts out news.

Follow Orthocell
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer